1. About these terms
This website is operated by Genexis Health Ltd.. By accessing it you agree to these terms and to our Medical Disclaimer and Privacy Policy. Where there is any conflict, the Medical Disclaimer prevails.
We may amend these terms. The version published here is the version in force.
2. What this site provides
This site publishes summaries of published research on peptides and related compounds, along with general safety information. It is an information resource and nothing more.
It is not medical advice, a diagnosis, a treatment recommendation, or a substitute for consultation with a qualified healthcare professional. See the Medical Disclaimer, which forms part of these terms.
3. Nothing is sold here
Genexis Health Ltd. does not sell, supply, broker or arrange the supply of any compound described on this site. No product is offered for sale, no order can be placed, and no enquiry leads to a supply of goods.
If any third party represents that they supply compounds on our behalf, or cites this site as an endorsement of a product, they do so without authority and without any relationship with us.
4. Acceptable use
You agree not to:
- Use this site if you are under 18 years of age;
- Present content from this site as medical advice, or as an endorsement of any product or supplier;
- Reproduce substantial parts of the site commercially, or in a way that implies we endorse what it is used for;
- Attempt to gain unauthorised access to the site or any system behind it;
- Use the site for any unlawful purpose.
We may restrict access where we reasonably believe these terms have been breached.
5. No warranty of accuracy
We prepare content carefully and link to primary sources so it can be checked independently. We do not, however, warrant that it is accurate, complete or current.
Research changes. A compound described as investigational may since have been approved, withdrawn or shown ineffective. Evidence grades are our editorial judgement, not an official classification, and reasonable people may read the same literature differently.
If you believe something here is wrong, please tell us at research@genexishealth.uk. See our corrections policy.
6. Limitation of liability
Nothing in these terms limits or excludes our liability for death or personal injury caused by our negligence, for fraud or fraudulent misrepresentation, or for any other liability that cannot lawfully be limited or excluded.
Subject to that paragraph, and to the fullest extent permitted by law:
- This site is provided on an "as is" and "as available" basis, without warranties of any kind;
- We accept no liability for any decision taken on the basis of information published here, including any decision to use, or not to use, any compound;
- We are not liable for any loss of profit, business, data or anticipated savings, or for any indirect or consequential loss;
- We are not liable for the content, products or conduct of any third party, including any supplier you may find independently.
7. Intellectual property
The content, design and code of this site are owned by or licensed to Genexis Health Ltd.. You may read, share and link to individual pages freely. You may not reproduce substantial portions commercially without written permission.
Brand names referred to on this site are the trademarks of their respective owners and are used only to identify the products they denote. Their use does not imply any association with or endorsement by those owners.
8. External links
We link to external sources, principally PubMed and regulatory bodies, so that claims can be verified at source. We do not control those sites and are not responsible for their content or availability. A link is not an endorsement.
9. Governing law
These terms, and any dispute arising out of or in connection with them, are governed by the laws of [Country] and subject to the exclusive jurisdiction of its courts. Where mandatory consumer law in your country of residence gives you rights that cannot be excluded, nothing here affects them.
If any provision is found unenforceable, the remainder continues in force.
Questions: research@genexishealth.uk.